Inspire Medical Systems
INSP
Market cap $5.63B

187.77 USD

+2.35

1.27%

At close Dec 20, 4:00 PM EST

After hours

186.00

-1.77

0.94%

1 day

1.27%

5 days

0.57%

1 month

1.62%

3 months

-11.78%

6 months

11.96%

Year to date

-0.04%

1 year

1.74%

5 years

160.32%

10 years

651.68%

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,011

Healthcare Surgical & Medical Instruments & Apparatus

0

Funds holding %

of 6,809 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

400% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 5 (+4) [Q3]

63% more capital invested

Capital invested by funds: $4.27B [Q2] → $6.96B (+$2.7B) [Q3]

32% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 60

6% more funds holding

Funds holding: 322 [Q2] → 341 (+19) [Q3]

3.47% more ownership

Funds ownership: 107.27% [Q2] → 110.74% (+3.47%) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 110

8% less call options, than puts

Call options by funds: $121M | Put options by funds: $131M

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$198

5%

upside

Avg. target

$238

27%

upside

High target

$260

38%

upside

7 analyst ratings

5 positive

71%

2 neutral

29%

0 negative

0%

B of A Securities Bob Hopkins 100% 1-year accuracy 2 / 2 met price target	36%upside $255	Buy Upgraded	20 Nov 2024
RBC Capital Shagun Singh 51% 1-year accuracy 40 / 78 met price target	38%upside $260	Outperform Reiterated	5 Nov 2024
Piper Sandler Adam Maeder 63% 1-year accuracy 10 / 16 met price target	38%upside $260	Overweight Reiterated	5 Nov 2024
Stifel Jonathan Block 22% 1-year accuracy 4 / 18 met price target	7%upside $200	Hold Reiterated	5 Nov 2024
Wells Fargo Larry Biegelsen 51% 1-year accuracy 24 / 47 met price target	5%upside $198	Equal-Weight Maintained	5 Nov 2024

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about INSP published over the past 30 days

Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

SAN MATEO, Calif.--(BUSINESS WIRE)-- #backpain--Presidio Medical, Inc., a clinical stage company developing a transformational neuromodulation platform, is pleased to announce Richard J. Buchholz will join its Board of Directors. Rick is the Chief Financial Officer of Inspire Medical Systems, Inc. (NYSE: INSP), where he has played a pivotal role in driving strategic financial and operational growth for the global leader in the development and commercialization of innovative, minimally invasive solutions fo.

Presidio Medical™ Announces Appointment of Richard J. Buchholz to Join its Board of Directors

Zacks Investment Research

5 Growth Stocks to Buy in December for Impressive Short-Term Upside

These five growth stocks have strong potential for December. These are: MNDY, PSN, PI, INSP, INGR.

5 Growth Stocks to Buy in December for Impressive Short-Term Upside

Zacks Investment Research

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

BofA Securities has upgraded Inspire Medical Systems, Inc. INSP and says the company now falls in the profitable growth category.

Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade

UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

MINNEAPOLIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.

UPDATED – Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program

MINNEAPOLIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire,” or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase (“ASR”) transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors.

Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program

Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

MINNEAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024.

Inspire Medical Systems, Inc. to Present at Jefferies London Healthcare Conference

Zacks Investment Research

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the third quarter.

INSP Stock Gains Following Q3 Earnings Beat, Gross Margin Contracts

Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript

Inspire Medical Systems, Inc. (NYSE:INSP ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Ezgi Yagci – Vice President-Investor Relations Tim Herbert – President and Chief Executive Officer Rick Buchholz – Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Danielle Antalffy – UBS Travis Steed – Bank of America Securities Adam Maeder – Piper Sandler David Rescott – Baird Michael Sarcone – Jefferies Richard Newitter – Truist Securities Larry Biegelsen – Wells Fargo Shagun Singh – RBC Kallum Titchmarsh – Morgan Stanley Jon Block – Stifel Anthony Petrone – Mizuho Americas Brett Fishbin – KeyBanc Capital Markets Chris Pasquale – Nephron Research Michael Polark – Wolfe Research Mike Kratky – Leerink Partners Suraj Kalia – Oppenheimer & Co Operator Good afternoon. My name is Dilem, and I'll be your conference operator today.

Inspire Medical Systems, Inc. (INSP) Q3 2024 Earnings Call Transcript

Zacks Investment Research

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings

Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About Inspire (INSP) Q3 Earnings

See News Rankings

Charts implemented using Lightweight Charts™